Showing results (241-250 of 324) with videos related to

Sort By:
Pageof 33
Clinical Genitourinary Cancer|December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 StudyFernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
Investigational New Drugs|May 4, 2026
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumorsAlejandro Falcón, Gregory M Cote, Javier Molina-Cerrillo, et al.
Urologic Oncology|May 15, 2026
Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective studyPatricia Rioja, Carolina Passarella, Martín Angel, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 19, 2018
Influence of Physical Exercise on the Dialytic Adequacy Parameters of Patients on HemodialysisAlicia García Testal, Rafael García Maset, David Hervás Marín, et al.
Circulation. Cardiovascular Interventions|January 11, 2019
Bicuspid Aortic Valve Anatomy and Relationship With Devices: The BAVARD Multicenter RegistryDidier Tchetche, Chiara de Biase, Lennart van Gils, et al.
Clinical & Experimental Metastasis|June 8, 2024
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 projectAlessandro Rizzo, Sebastiano Buti, Patrizia Giannatempo, et al.
Targeted Oncology|August 10, 2022
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination TherapiesMatteo Santoni, Javier Molina-Cerrillo, Zin W Myint, et al.
Stem Cell Reports|January 24, 2017
A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem CellsSeonmi Park, Andreia Gianotti-Sommer, Francisco Javier Molina-Estevez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo, et al.
Pageof 33